Eurofins Scientific SE
ERF
Rang in aandelen
#1379
Eurofins Scientific SE, together with its subsidiaries, provides various... Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. It provides services, such as agroscience, including biological assessment, consumer and human, environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, including sustainability, audit, certification, quality inspection, QA-QC programme, and food and dietary supplement labelling services; biopharma, and clinical diagnostics. The company also offers consumer product testing, which include sustainability, testing, certifications and approvals, expert services and regulatory, inspections, audits, consumer research and sensory evaluation, and training courses; cosmetics and personal care; and electrical and electronics laboratories services. In addition, it provides environment testing, including maritime, water, air, soil, building material, pollution, waste, fuel/oil, microplastics, and radioactivity testing; and food and feed testing that include allergen, audit and certification, authenticity, carbohydrates, consulting, dioxins and POPs, food irradiation, GMO, heavy metal, melamine, microbiology, molecular biology, mycotoxin, nutritional analyses, organic contaminants, pesticide, veterinary drug, vitamin, and residual DNA testing. Further, the company provides forensic, genomic, maritime, materials and engineering, REACH, and sensory and consumer services, as well as in vitro diagnostics and PSS insourcing solutions. The company was founded in 1987 and is headquartered in Luxembourg, Luxembourg.
Aandeelprijs
$93.33
Laatst gesynchroniseerd: 2026-10-20
Marktkapitalisatie
$16.20B
Verandering (1 dag)
-0.33%
Verandering (1 jaar)
28.73%
Land
LU
Handel Eurofins Scientific SE (ERF)
Categorie
Healthcare
Winst voor Eurofins Scientific SE (ERF)
Winst in Jun 2026 TTM: $862.10M
Volgens de meest recente financiële verslagen van Eurofins Scientific SE bedraagt de huidige winst van het bedrijf $862.10M. In 2024 behaalde het bedrijf een winst van $577.10M, een stijging ten opzichte van de winst van 2023, die $467.94M bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van Eurofins Scientific SE van 2002 tot 2026
Winst aan het einde van elk jaar
| Jaar | Winst | Wijzigen |
|---|---|---|
| 2026 (TTM) | $862.10M | 12.35% |
| 2025 | $767.32M | 32.96% |
| 2024 | $577.10M | 23.33% |
| 2023 | $467.94M | -44.07% |
| 2022 | $836.69M | -30.36% |
| 2021 | $1.20B | 42.07% |
| 2020 | $845.69M | 177.62% |
| 2019 | $304.62M | -8.54% |
| 2018 | $333.07M | 10.99% |
| 2017 | $300.10M | 17.56% |
| 2016 | $255.27M | 77.62% |
| 2015 | $143.72M | 17.22% |
| 2014 | $122.61M | 0.11% |
| 2013 | $122.48M | 13.68% |
| 2012 | $107.74M | 18.11% |
| 2011 | $91.22M | 88.59% |
| 2010 | $48.37M | -1,720.16% |
| 2009 | $-2.99M | -107.78% |
| 2008 | $38.37M | -9.89% |
| 2007 | $42.58M | 4.56% |
| 2006 | $40.72M | 46.24% |
| 2005 | $27.85M | 72.80% |
| 2004 | $16.11M | 196.15% |
| 2003 | $5.44M | 145.28% |
| 2002 | $2.22M | 0.00% |
Winst van vergelijkbare bedrijven of concurrenten
| Bedrijf | Winst | Winstverschil | Land |
|---|---|---|---|
| $7.61B | 782.61% |
US
|
|
| $4.76B | 452.37% |
US
|
|
| $-252.70M | -129.31% |
US
|
|
| - | - |
CN
|
|
| $1.66B | 92.32% |
US
|
